ClearWater Paper Corporation (CLW) Actualités

Form 8-K - Current report

Clearwater Paper Enters into Definitive Agreement to Sell Tissue Business to Sofidel America Corporation for $1.06 Billion

Advances Transformation into a Premier Independent Supplier of Paperboard to North American Converters Transaction to Accelerate Ongoing Efforts...

Clearwater Paper Announces Availability and Timing of Second Quarter 2024 Earnings Conference Call and Webcast

Clearwater Paper Corporation (NYSE: CLW) will release its second quarter 2024 results on Tuesday, August 6, 2024 after market close. President...

Form 4 - Statement of changes in beneficial ownership of securities

Clearwater Paper to Invest $23 Million in Shelby, N.C. New State-of-the-Art Facial Tissue Line

Clearwater Paper Corporation (NYSE: CLW), a leading supplier of private-branded tissue, announced today it will invest $23 million in a new...

Clearwater Paper Announces Upcoming Investor Conference Participation

Clearwater Paper Corporation (NYSE: CLW) today announced upcoming participation in the following investor conferences: June 4, 2024 – President...

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Clearwater Paper Announces Closing of the Augusta Paperboard Manufacturing Facility Acquisition

Acquisition to Enhance Existing Capabilities in Paperboard Manufacturing Clearwater Paper Corporation (NYSE:CLW) today announced the successful...

Clearwater Paper Reports First Quarter 2024 Results

Clearwater Paper Corporation (NYSE:CLW), a premier supplier of quality consumer tissue and bleached paperboard today reported financial results...

Clearwater Paper Announces Availability and Timing of First Quarter 2024 Earnings Conference Call and Webcast

Clearwater Paper Corporation (NYSE: CLW) will release its first quarter 2024 results on Monday, April 29, 2024. President and Chief Executive...

Form PRE 14A - Other preliminary proxy statements

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities